MarkSSolowayMD

PubMed

• 1 citations
  Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancer.
  Vitug, C., Lajkosz, K., Chavarriaga, J., Llano, A., Din, S., Villegas, E., Kuk, C., Chan, A., Gao, B., Hemminki, O., Kot, D., Misurka, J., van der Kwast, T., Wallis, C...> ;BJU International. 2024 Mar 1
• Editorial Comment.
  Mark S Soloway> ;Urology Practice. 2024 Jan 1
• Reply by Authors.
  Wei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, Giovanni Lughezzani, Valentina Grajales, Mark Soloway, Paolo Casale, Rodolfo Hurle, Ashish M Kamat> ;The Journal of Urology. 2023 Nov 1
• International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance.
  Wei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, Giovanni Lughezzani, Valentina Grajales, Mark Soloway, Paolo Casale, Rodolfo Hurle, Ashish M Kamat> ;The Journal of Urology. 2023 Nov 1
• Editorial Comment.
  Mark S Soloway> ;Urology Practice. 2023 Sep 1
• 6 citations
  Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma.
  Jiaojiao Wang, Andre R Jordan, Huabin Zhu, Sarrah L Hasanali, Eric Thomas, Soum D Lokeshwar, Daley S Morera, Sung Alexander, Joseph McDaniels, Anuj Sharma, Karina Agui...> ;Cancer Cell International. 2022 Dec 29
• Patient tolerability during office cystoscopy and bladder tumor cauterization: a multivariate analysis of risk factors.
  S D Lokeshwar, S N Rahman, A Choksi, B H Press, D Shaheen, M S Soloway> ;Actas Urologicas Espanolas. 2023 Apr 1
• 27 citations
  International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladde...
  Mathieu Roumiguié, Ashish M Kamat, Trinity J Bivalacqua, Seth P Lerner, Wassim Kassouf, Andreas Böhle, Maurizio Brausi, Roger Buckley, Raj Persad, Marc Colombel, Donal...> ;European Urology. 2022 Jul 1
• 2 citations
  Surveillance and office management of low-grade Ta bladder tumors.
  S D Lokeshwar, S N Rahman, B H Press, A I Khan, M S Soloway> ;Actas Urologicas Espanolas. 2022 Dec 1
• 1 citations
  Diffuse large B-cell lymphoma presenting as LUTS: Clinical practice points.
  Soum D. Lokeshwar, Syed N. Rahman, Jamil Syed, Thomas F. Monaghan, Benjamin Press, Mark S. Soloway> ;Urology Case Reports. 2022 Jan 1
• 2 citations
  Cisplatin, Neoadjuvant Chemotherapy and Bladder Cancer.
  Harry W. Herr, Mark Soloway> ;Urology. 2021 Nov 1
• 25 citations
  Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours.
  Hugh Mostafid, Ashish M. Kamat, Siamak Daneshmand, Joan Palou, John A. Taylor, James M. McKiernan, James W.F. Catto, Marko Babjuk, Mark S. Soloway> ;European Urology Oncology. 2021 Feb 1
• The Fallacy of "Definitive Therapy" for Prostate Cancer.
  Mark S Soloway, Soum D. Lokeshwar> ;European Urology. 2020 Aug 6
• 28 citations
  Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer.
  Hugh Mostafid, Marko Babjuk, Bernard H. Bochner, Seth P. Lerner, Fred Witjes, Joan Palou, Morgan Rouprêt, S.F. Shariat, Paolo Gontero, Bas W.G. van Rhijn, Richard Zige...> ;European Urology. 2020 Jun 1
• 9 citations
  Molecular targeting of renal cell carcinoma by an oral combination
  Andre R. Jordan, Jiaojiao Wang, Travis Yates, Sarrah L. Hasanali, Soum D. Lokeshwar, Daley S. Morera, Nagarajarao Shamaladevi, Charles S. Li, Zachary Klaassen, Martha ...> ;Oncogenesis. 2020 May 19
• 26 citations
  Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)
  Justin T. Matulay, Mark S. Soloway, J. Alfred Witjes, Roger Buckley, Raj Persad, Donald L. Lamm, Andreas Boehle, Joan Palou, Marc Colombel, Maurizio Brausi, Ashish M. ...> ;BJU International. 2020 Apr 1
• 3 citations
  A Case for Risk-adapted Management of Low-grade Bladder Tumors
  Mark S. Soloway, Justin T. Matulay, Ashish M. Kamat> ;European Urology Oncology. 2020 Feb 1
• 28 citations
  Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.
  Daley S. Morera, Sarrah L. Hasanali, Santu Ghosh, Zachary Klaassen, Andre R. Jordan, Jiaojiao Wang, Martha K. Terris, Roni J. Bollag, Axel S. Merseburger, Arnulf Stenz...> ;The Journal of Urology. 2020 Jan 1
• Editorial Commentary.
  Mark S Soloway> ;Urology Practice. 2019 May 1
• 88 citations
  BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG.
  Ashish M. Kamat, Marc Colombel, Debasish Sundi, Donald L. Lamm, Andreas Boehle, Maurizio Brausi, Roger Buckley, Raj Persad, Joan Palou, Mark S. Soloway, J. Alfred Witjes> ;Nature Reviews. Urology. 2017 Apr 1
• 36 citations
  Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer
  Mario I. Fernández, Maurizio Brausi, Peter E. Clark, Michael S. Cookson, H. Barton Grossman, Makarand Khochikar, Lambertus A. Kiemeney, Bernard Malavaud, Rafael Sanche...> ;World Journal of Urology. 2019 Jan 1
• 1 citations
  A Festschrift in Honor of Edward M. Messing, MD, FACS.
  Jean V. Joseph, R.A. Brasacchio, Chunkit Fung, Jay E. Reeder, Kevin Bylund, Deepak M. Sahasrabudhe, Shuyuan Yeh, Ahmed Ghazi, Patrick J. Fultz, Deborah J. Rubens, Guan...> ;Bladder Cancer. 2018 Oct 3
• Challenging Cases in Urothelial Cancer.
  Mark S Soloway> ;Bladder Cancer. 2018 Oct 29
• Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours - why is it not routine?
  Mark S. Soloway> ;BJU International. 2018 Oct 1
• 8 citations
  Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for...
  Lawrence Karsh, Neal D. Shore, Mark S. Soloway, Gajanan Bhat, Guru Reddy, Szu-Yun Leu, J. Alfred Witjes> ;Bladder Cancer. 2018 Jul 30
• Join now to see all

Journal Articles

• Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.  
  Collier D, Soloway MS, Urology, 8(5):459-464
• Radiation therapy of experimental murine bladder cancer - synergism with cisplatinum diamminedichloride.  
  Soloway MS, Gehrki G, Surg Forum, 28:559-561
• The importance of transurethral resection in managing patients with urothelial cancer in the bladder: proposal for a transurethral resection of bladder tumor checklist.  
  Pan D, Soloway MS, Eur Urol, 61(6):1199-203
• Intravesical and systemic chemotherapy of murine bladder cancer.  
  Soloway MS, Cancer Res, 37(8 Pt 2):2918-2929
• Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption.  
  Ayyathurai R, Garcia-Roig M, Gorin MA, González J, Manoharan M, Kava BR, Soloway MS, Ciancio G, BJU Int
• Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.  
  Iremashvili V, Manoharan M, Rosenberg DL, Soloway MS, BJU Int
• Malignant penile horn.  
  Raghavaiah NV, Soloway MS, Murphy WM, J Urol, 118(6):1068-1069
• Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) Over Time Among Men Treated for Localized Prostate Cancer.  
  Cruess DG, Benedict C, Lattie EG, Molton I, Kinsinger D, Kava B, Manoharan M,Soloway M, Penedo F, J Pers Assess
• Hematocolpos with urinary tract obstruction in an adult.  
  Soloway MS, Rao MK, Kest L, J Urol, 117(6):811-812
• Androgen deprivation prior to radical prostatecotmy in T2b prostate specific antigen.  
  Hachiya T, Soloway MS, Ruiz, H.E., and Gomez C.A, Jap J Urology, 7(6):585-590
• The clinical value of urinary carcinoembryonic antigen-like substances in urothelial cancer.  
  Murphy WM, Vandevoorde JP, Rao MK, Soloway MS, J Urol, 118(5):806-808
• Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.  
  Soloway MS, Lopez AE, Patel J, Lu Y, Cancer, 73(7):1926-1931
• Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy.  
  Grossman HB, Stenzl A, Fradet Y, Mynderse LA, Kriegmair M, Witjes JA, Soloway MS, Karl A, Burger M, J Urol, 188: 58-62
• Anuria following silver nitrate irrigation for intractable bladder hemorrhage.  
  Raghavaiah NV, Soloway MS, J Urol, 118(4):681-682
• Intravesical therapy for bladder cancer.  
  Soloway MS, J Urol, 152(2 Pt 1):379-381
• Morphologic effects of thio-TEPA on mouse urothelium.  
  Murphy WM, Soloway MS, Lin CJ, Acta Cytol, 21(5):701-704
• Androgen deprivation prior to radical prostatectomy for T2b and T3 prostate cancer.  
  Soloway MS, Hachiya T, Civantos F, Murphy WM, Gomez CC, Ruiz HE, Urology, 43(2 Suppl):52-56
• Impact of body mass index and tumor location on the incidence of benign histology at the time of nephron-sparing surgery.  
  Kava BR, Eldefrawy A, Ayyathurai R, Manoharan M, Aziz M, Bird VG, Katkoori D, Ramanathan R, Jorda M, Ciancio G, Soloway MS, Leveillee RJ, Int Urol Nephrol, 44(5): 1319-24
• The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.  
  Murphy GP, Gibbons RP, Johnson DE, Prout GR, Schmidt JD, Soloway MS, Loening SA, Chu TM, Gaeta JF, Saroff J, Wajsman Z, Slack N, Scott WW, Trans Am Assoc Genitourin Surg, 70:69-71
• Diagnosis and treatment of bladder cancer: how can we improve?  
  Gorin MA, Ayyathurai R, Soloway MS, Postgrad Med, 124(3): 28-36
• Possible interaction of indomethacin and warfarin.  
  Self TH, Soloway MS, and Vaughan, D, Drug Intel Clin Pharm, 12:580-581
• Stage T1A carcinoma of prostate.  
  Matzkin H, Patel JP, Altwein JE, Soloway MS, Urology, 43(1):11-21
• Active Surveillance for Prostate Cancer: A Systematic Review of the Literature.  
  Dall'era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS, Eur Urol
• Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.  
  Soloway MS, Natl Cancer Inst Monogr, (49):327-332
• Sampling of radical prostatectomy specimens. How much is adequate?  
  Cohen MB, Soloway MS, Murphy WM, Am J Clin Pathol, 101(3):250-252
• Join now to see all

Books/Book Chapters

• Brain and Blood Flow. 
  Chapter: The effect of delayed hyperventilation on experimental middle cerebral artery occlusion 
  Page 98 - 101Soloway MS, Moriarty, G., Fraser, J., and White, R.JEditors: R.W. Ross Russel.Pitman Medical Publishing Company, London
• Chemotherapy of Urogenital Tumors. 
  Chapter: Animal models used for experimental chemotherapy of genitourinary tract tumors 
  Soloway MSEditors: Murphy, G.P., and Mittelman, A.Charles C. Thomas, Springfield
• Urology in Practice. 
  Chapter: Urothelial tumors 
  Page 653 - 690Persky, L., Krush, E.D., and Soloway MSEditors: Devine, Charles J., Jr., and Stecker, John F., Jr.Little Brown and Company, Boston
• Advances in Medical Oncology, Research and Education. 
  Chapter: The management of superficial bladder cancer 
  Page 241 - 250Soloway MSEditors: Wilkinson, P.M.Pergamon press, Oxford and New York
• Cis-platin: Current Status and New Developments. 
  Chapter: Cis-platin analogs and combination chemotherapy in the therapy of murine bladder cancer 
  Page 345 - 359Soloway MS, Masters, S.B., and Murphy, W.MEditors: Prestayko, A.W., Crooke, S.T., and Carter, S.K.Academic Press, New York
• Cis-platin Derzeitiger Stand und neue Entwicklunger in der Chemotherapie malinger Neoplasien. 
  Chapter: Cis-diamminedichloroplatinum (II) in locally advanced dn metastatic urothelial cancer 
  Page 131 - 140Soloway MSEditors: Seeber, S., Schmidt, C.G., Nagel, G., and Achterrath, W.Basel, Munchen, Paris, London, New York, and Sydney
• Bladder Cancer - Principles of Combination Therapy. 
  Chapter: Chemotherapy of murine bladder cancer 
  Page 37 - 55Soloway MS and Murphy, W.MEditors: Oliver, R.T.D., Hendry, W.F., Bloom, H.J.G.Butterworths and Company, London
• Bladder Cancer. 
  Chapter: Clinical and experimental aspects of therapy 
  Page 74 - 95Soloway MS and Kerr, W.KEditors: Skrabanek, P. and Walsh, A.International Union Against Cancer, Geneva
• Pharmacology of the Urinary Tract and the Male Reproductive System. 
  Chapter: Chemotherapy of urologic cancer 
  Page 53 - 102Soloway MS, Yagoda, A., and Mickey, D.DEditors: Finkbeiner, A.E., Barbour, G.L., and Bissada, N.K.Appleton-Century-Crofts, New York
• Pathology Annual, Part 1, Volume 17. 
  Chapter: Developing carcinoma (dysplasia) of the urinary bladder 
  Page 197 - 217Murphy, W.M. and Soloway MSEditors: Sommers, S.C., and Rosen, P.P.Appleton-Century-Crofts, New York
• Chemotherapy and Urological Malignancy. 
  Chapter: Intravesical chemotherapy for superficial bladder cancer 
  Page 50 - 71Soloway MSEditors: Spiers, A.S.D.Springer-Verlag, New York
• Genitourinary Tumors: Fundamental Principles and Surgical Techniques. 
  Chapter: Radical cystectomy: Male 
  Page 467 - 477Soloway MSEditors: Johnson, D.E. and Boileau, M.A.Grune and Stratton, New York
• Principles and Management of Urologic Cancer. 
  Chapter: Management of superficial bladder cancer 
  Page 446 - 466Soloway MSJavadpour, Williams and Wilkins, Baltimore
• Progress and Controversies in Oncological Urology. 
  Chapter: Rationale for intensive intravesical chemotherapy 
  Page 287 - 296Soloway, M.D.Editors: Kueth, K.H., Debruyne F.M.G., Schroeder, F.S., Splinter, T.Q.W., Wagener, T.D.J.Alan R. Liss, Inc, New York
• Bladder Cancer. Part A. Pathology, Diagnosis, and Surgery. 
  Chapter: Role of selected mucosal biopsies in the evaluation of patients with bladder cancer 
  Page 275 - 281Soloway MS and Bicknell, LEditors: Kuss, R., Khoury, S., Denis, L., Murphy, G.P., and Karr, J.P.Alan R. Liss, Inc, New York
• Urologic Clinics of North America, Volume 11. 
  Chapter: Intravesical and systemic chemotherapy in the management of superficial bladder cancer 
  Soloway MS
• Genitourinary Cancer - Contemporary Issues in Clinical Oncology. 
  Chapter: Intravesical chemotherapy in superficial bladder cancer 
  Page 163 - 192Soloway MSEditors: Garnick, Mark B.Churchill Livingston, New York
• Testicular Cancer and Other Tumors of the Genitourinary Tract. 
  Chapter: The use of an animal model to gain insights into bladder cancer therapy 
  Page 315 - 327Soloway MSEditors: Pavone-Macaluso, M., Smith, P.H. and Bagshaw, M.A.Plenum Publishing Corp, New York, London, Washington, D.C
• Testicular Cancer and Other Tumors of the Genitourinary Tract. 
  Chapter: Treatment of advanced bladder cancer 
  Page 411 - 424Soloway MSEditors: Pavone-Macaluso, M., Smith, P.H., and Bagshaw, M.A.Plenum Publishing Corp, New York, London, Washington, D.C
• Testicular Cancer and Other Tumors of the Genitourinary Tract. 
  Chapter: Chemotherapy for prostate cancer - the experience of the National Prostatic Cancer Project 
  Page 467 - 474Soloway MSEditors: Pavone-Macaluso, M., Smith, P.H., and Bagshaw, M.A.Plenum Publishing Corp, New York, London, Washington, D.C
• Developments in Bladder Cancer. 
  Chapter: Surgical techniques in the management of patients with superficial bladder cancer 
  Page 123 - 132Soloway MS, Kurth, K.H., Herr, H., Huland, H., Denis, L., Suzuki, K., Blandy, J., Hisazumi, H., Koontz, W., and Tsugawa, REditors: Denis,L., Niijima, T., Prout, G. Jr., and Schroeder, F.H.Alan R. Liss, Inc., New York
• Progress in Clinical and Biological Research, Volume 221. 
  Chapter: Prognostic factors in superficial bladder cancer. In: Developments in Bladder Cancer 
  Page 257 - 269Aso, Y., Anderson, L., Soloway, M., Bouffioux, C., Chisholm, G., Debruyne, F., Kawai, T., Kurth, K.H., Maru, A., and Straffon, W.G.EEditors: Denis, L., Niijima, T., Prout, G. Jr., and Schroeder, F.H.Alan R. Liss, Inc, New York
• Current Therapy in Genito-Urinary Surgery. 
  Chapter: Superficial transitional cell carcinoma 
  Page 53 - 56Soloway MSEditors: Resnick, M.I., and Kursh, E. B.C.Decker, Inc, Toronto
• The Management of Bladder Cancer. 
  Chapter: The management of superficial bladder cancer, with emphasis on intravesical chemotherapy 
  Page 118 - 139Soloway MSEditors: Raghavan, D.Edward Arnold, Ltd, London
• Controversies in Urology. 
  Chapter: The case for chemotherapy as the initial management of patients with carcinoma in situ of the urinary bladder 
  Page 237 - 241Soloway MSEditors: Carlton, C.E., Jr.Yearbook Medical Publishers, Chicago
• Join now to see all

Abstracts/Posters

• The salutary effect of lower arterial pCO2 in experimental cerebral infarction.
  White, R.J., Soloway MS, Nadel, W., Yashon, D. and Albin, M.S, Fourth International Congress of Neurological Surgery

Lectures

• Gender-Specific Considerations in Healthcare - CME Getaways South Beach 
  CME Getaways, Miami Beach, Florida - 11/30/2012
• The effect of chronic immunosuppression on the chemical induction of bladder cancer. 
  Annual Meeting of North Central Section of American Urological Association, Chicago, Illinois
• Chemo and immuno therapy of superficial bladder tumors, T1s, Ta and T1. 
  European Association of Urology 19th Congress, Amsterdam, The Netherlands
• Advances and Controversies in Urological Oncology. 
  Erice, Italy
• The effect of regional lymphadenectomy on the development of concomitant immunity. 
  Annual Meeting of American College of Surgeons, San Francisco, California
• Rationale for intravesical treatment. Mini Symposium - superficial bladder cancer. 
  European Association of Urology 19th Congress, Amsterdam, The Netherlands
• New concepts on treatment of superficial bladder cancer. 
  Erice, Italy
• Evaluation of urinary cytology as an indicator of bladder neoplasia in mice. 
  Annual Meeting of American Society of Cytologists, New Orleans, Louisiana
• A randomized controlled trial of Leuprolide and Anandron versus Leuprolide and placebo for advanced prostate cancer. 
  European Association of Urology 19th Congress, Amsterdam, The Netherlands
• Case based discussion of management issues in urothelial carcinoma of the urinary tract. 
• Effect of chemotherapeutic agents on bladder cancer: A new animal model. 
  Multiple Loactions, 1973
• Mitomycin C for intravesical chemotherapy. 
  15th Intl Cancer Congress, Hamburg, Fed Republic of Germany
• Annual Perspectives in Bladder Cancer. 
  Seville, Spain
• Single and combination chemotherapy for primary murine bladder cancer. 
  Houston, Texas, 1974; Columbus, Ohio, 1974
• Multiple recurrent tumors of the urinary bladder. 
  Advanced Annual Seminar of Urologic Surgery, San Francisco, California
• Current controversies in the chemotherapy for bladder and prostate cancer. 
  University of Toronto, Division of Urology, Toronto, Canada
• Overview of androgen blockade therapy and androgen deprivation prior to radical prostatectomy. 
  Chicago, Illinois, 1990; Orlando, Florida, 1993
• Management of T1-T2 prostate cancer with an emphasis on technical modifications of radical prostatectomy and Critical management decisions in the management of Ta, T1 ... 
  Kingston, Jamaica
• Urothelial susceptibility to neoplastic cellular implantation. 
  Annual meeting of American College of Surgeons, Miami, Florida
• Overview of chemotherapy for GU tumors. 
  Southeast Section of the American Urological Association, Atlanta, Georgia
• Treatment modalities for prostate cancer. 
  Bay State Medical Center, Springfield, Massachusetts
• Highlights of the SIU Consensus Conference on Bladder Cancer. 
  Ottawa , Canada
• A murine model to evaluate intravesical chemotherapy. 
  Annual Meeting of Association for Academic Surgeons, Los Angeles, California
• Current management of metastatic bladder cancer. 
  Advanced Annual Seminar of Urologic Surgery, San Francisco, California
• Methods and criteria for clinical assessment of carcinoma in situ. 
  University of Kentucky, Lexington, Kentucky
• Join now to see all

Other

• Optimal management of the T1G3 bladder cancer. 
  Manoharan M, Soloway MS, Urol Clin North Am 2005 May; 32(2):133-45